Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 190

1.

Realizing the potential of routine viral load testing in sub-Saharan Africa.

El-Sadr WM, Rabkin M, Nkengasong J, Birx DL.

J Int AIDS Soc. 2017 Nov;20 Suppl 7. doi: 10.1002/jia2.25010. No abstract available.

2.

HIV-1 Genetic Diversity Among Incident Infections in Mbeya, Tanzania.

Billings E, Sanders-Buell E, Bose M, Kijak GH, Bradfield A, Crossler J, Arroyo MA, Maboko L, Hoffmann O, Geis S, Birx DL, Kim JH, Michael NL, Robb ML, Hoelscher M, Tovanabutra S.

AIDS Res Hum Retroviruses. 2017 Apr;33(4):373-381. doi: 10.1089/AID.2016.0111. Epub 2016 Dec 19.

3.

Advancing PMTCT Implementation Through Scientific Research: A Vital Agenda for Combating the Global AIDS Epidemic in Low- and Middle-Income Countries.

Glass RI, Birx DL.

J Acquir Immune Defic Syndr. 2016 Aug 1;72 Suppl 2:S101. doi: 10.1097/QAI.0000000000001076. No abstract available.

PMID:
27355495
4.

Sequential Dysfunction and Progressive Depletion of Candida albicans-Specific CD4 T Cell Response in HIV-1 Infection.

Liu F, Fan X, Auclair S, Ferguson M, Sun J, Soong L, Hou W, Redfield RR, Birx DL, Ratto-Kim S, Robb ML, Kim JH, Michael NL, Hu H.

PLoS Pathog. 2016 Jun 9;12(6):e1005663. doi: 10.1371/journal.ppat.1005663. eCollection 2016 Jun.

5.

Safety and Immunogenicity of a Randomized Phase 1 Prime-Boost Trial With ALVAC-HIV (vCP205) and Oligomeric Glycoprotein 160 From HIV-1 Strains MN and LAI-2 Adjuvanted in Alum or Polyphosphazene.

O'Connell RJ, Excler JL, Polonis VR, Ratto-Kim S, Cox J, Jagodzinski LL, Liu M, Wieczorek L, McNeil JG, El-Habib R, Michael NL, Gilliam BL, Paris R, VanCott TC, Tomaras GD, Birx DL, Robb ML, Kim JH.

J Infect Dis. 2016 Jun 15;213(12):1946-54. doi: 10.1093/infdis/jiw059. Epub 2016 Feb 11.

6.

The Vancouver Consensus: antiretroviral medicines, medical evidence, and political will.

Beyrer C, Birx DL, Bekker LG, Barré-Sinoussi F, Cahn P, Dybul MR, Eholié SP, Kavanagh MM, Katabira ET, Lundgren JD, Mworeko L, Pala M, Puttanakit T, Ryan O, Sidibé M, Montaner JS; Vancouver Consensus Signatories.

Lancet. 2015 Aug 8;386(9993):505-7. doi: 10.1016/S0140-6736(15)61458-1. No abstract available.

PMID:
26293427
7.

The Number and Complexity of Pure and Recombinant HIV-1 Strains Observed within Incident Infections during the HIV and Malaria Cohort Study Conducted in Kericho, Kenya, from 2003 to 2006.

Billings E, Sanders-Buell E, Bose M, Bradfield A, Lei E, Kijak GH, Arroyo MA, Kibaya RM, Scott PT, Wasunna MK, Sawe FK, Shaffer DN, Birx DL, McCutchan FE, Michael NL, Robb ML, Kim JH, Tovanabutra S.

PLoS One. 2015 Aug 19;10(8):e0135124. doi: 10.1371/journal.pone.0135124. eCollection 2015.

8.

Molecular evolution of the HIV-1 Thai epidemic between the time of RV144 immunogen selection to the execution of the vaccine efficacy trial.

Kijak GH, Tovanabutra S, Rerks-Ngarm S, Nitayaphan S, Eamsila C, Kunasol P, Khamboonruang C, Thongcharoen P, Namwat C, Premsri N, Benenson M, Morgan P, Bose M, Sanders-Buell E, Paris R, Robb ML, Birx DL, De Souza MS, McCutchan FE, Michael NL, Kim JH.

J Virol. 2013 Jul;87(13):7265-81. doi: 10.1128/JVI.03070-12. Epub 2013 Apr 10. Erratum in: J Virol. 2013 Dec;87(23):13084.

9.

Risk factors for HIV-1 infection in a longitudinal, prospective cohort of adults from the Mbeya Region, Tanzania.

Geis S, Maboko L, Saathoff E, Hoffmann O, Geldmacher C, Mmbando D, Samky E, Michael NL, Birx DL, Robb ML, Hoelscher M.

J Acquir Immune Defic Syndr. 2011 Apr 15;56(5):453-9. doi: 10.1097/QAI.0b013e3182118fa3.

10.

Socio-demographic and drug use factors associated with HIV-1 recombinants and dual infections in Northern Thai drug users: associations of risk with genetic complexity.

Kijak GH, Beyrer C, Tovanabutra S, Sripaipan T, Suriyanon V, Moqueet N, Sanders-Buell E, Saokhieo P, Timpan U, Jittiwutikarn J, Robb ML, Birx DL, Celentano DD, McCutchan FE.

Drug Alcohol Depend. 2011 Jul 1;116(1-3):24-30. doi: 10.1016/j.drugalcdep.2010.11.013. Epub 2010 Dec 28.

PMID:
21193272
11.

Multivalent dendrimeric compounds containing carbohydrates expressed on immune cells inhibit infection by primary isolates of HIV-1.

Rosa Borges A, Wieczorek L, Johnson B, Benesi AJ, Brown BK, Kensinger RD, Krebs FC, Wigdahl B, Blumenthal R, Puri A, McCutchan FE, Birx DL, Polonis VR, Schengrund CL.

Virology. 2010 Dec 5;408(1):80-8. doi: 10.1016/j.virol.2010.09.004. Epub 2010 Sep 28.

12.

The World Health Organization African region laboratory accreditation process: improving the quality of laboratory systems in the African region.

Gershy-Damet GM, Rotz P, Cross D, Belabbes el H, Cham F, Ndihokubwayo JB, Fine G, Zeh C, Njukeng PA, Mboup S, Sesse DE, Messele T, Birx DL, Nkengasong JN.

Am J Clin Pathol. 2010 Sep;134(3):393-400. doi: 10.1309/AJCPTUUC2V1WJQBM.

PMID:
20716795
13.

HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: evolutionary relics?

Carr JK, Wolfe ND, Torimiro JN, Tamoufe U, Mpoudi-Ngole E, Eyzaguirre L, Birx DL, McCutchan FE, Burke DS.

Retrovirology. 2010 Apr 28;7:39. doi: 10.1186/1742-4690-7-39.

14.

A phase 1/2 study of a multiclade HIV-1 DNA plasmid prime and recombinant adenovirus serotype 5 boost vaccine in HIV-Uninfected East Africans (RV 172).

Kibuuka H, Kimutai R, Maboko L, Sawe F, Schunk MS, Kroidl A, Shaffer D, Eller LA, Kibaya R, Eller MA, Schindler KB, Schuetz A, Millard M, Kroll J, Dally L, Hoelscher M, Bailer R, Cox JH, Marovich M, Birx DL, Graham BS, Michael NL, de Souza MS, Robb ML.

J Infect Dis. 2010 Feb 15;201(4):600-7. doi: 10.1086/650299.

15.

Short communication: HIV type 1 genetic diversity among tea plantation workers in Kericho, Kenya.

Arroyo MA, Sateren WB, Foglia G, Kibaya R, Langat L, Wasunna M, Bautista CT, Scott PT, Shaffer DN, Robb ML, Michael NL, Birx DL, McCutchan FE.

AIDS Res Hum Retroviruses. 2009 Nov;25(11):1061-4. doi: 10.1089/aid.2009.0092.

PMID:
19943788
16.

HIV-1 incidence rates and risk factors in agricultural workers and dependents in rural Kenya: 36-month follow-up of the Kericho HIV cohort study.

Shaffer DN, Ngetich IK, Bautista CT, Sawe FK, Renzullo PO, Scott PT, Kibaya RM, Imbuki KO, Michael NL, Birx DL, Wasunna MK, Robb ML.

J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):514-21. doi: 10.1097/QAI.0b013e3181bcdae0.

PMID:
19855286
17.

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand.

Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R, Premsri N, Namwat C, de Souza M, Adams E, Benenson M, Gurunathan S, Tartaglia J, McNeil JG, Francis DP, Stablein D, Birx DL, Chunsuttiwat S, Khamboonruang C, Thongcharoen P, Robb ML, Michael NL, Kunasol P, Kim JH; MOPH-TAVEG Investigators.

N Engl J Med. 2009 Dec 3;361(23):2209-20. doi: 10.1056/NEJMoa0908492. Epub 2009 Oct 20.

18.

Design and evaluation of multi-gene, multi-clade HIV-1 MVA vaccines.

Earl PL, Cotter C, Moss B, VanCott T, Currier J, Eller LA, McCutchan F, Birx DL, Michael NL, Marovich MA, Robb M, Cox JH.

Vaccine. 2009 Sep 25;27(42):5885-95. doi: 10.1016/j.vaccine.2009.07.039. Epub 2009 Aug 3.

19.

Serum levels of MIP-1beta and RANTES in HIV-1 subtype CRF01_AE infected patients with different rates of disease progression.

Chuenchitra T, Wasi C, de Souza M, Nitayaphan S, Louisirirotchanakul S, Sutthent R, Brown AE, Birx DL, Polonis VR.

Southeast Asian J Trop Med Public Health. 2008 Sep;39(5):856-62.

PMID:
19058580
20.

Reference ranges for the clinical laboratory derived from a rural population in Kericho, Kenya.

Kibaya RS, Bautista CT, Sawe FK, Shaffer DN, Sateren WB, Scott PT, Michael NL, Robb ML, Birx DL, de Souza MS.

PLoS One. 2008 Oct 3;3(10):e3327. doi: 10.1371/journal.pone.0003327.

21.

Variable contexts and levels of hypermutation in HIV-1 proviral genomes recovered from primary peripheral blood mononuclear cells.

Kijak GH, Janini LM, Tovanabutra S, Sanders-Buell E, Arroyo MA, Robb ML, Michael NL, Birx DL, McCutchan FE.

Virology. 2008 Jun 20;376(1):101-11. doi: 10.1016/j.virol.2008.03.017. Epub 2008 Apr 24.

22.

Cross-clade neutralization patterns among HIV-1 strains from the six major clades of the pandemic evaluated and compared in two different models.

Brown BK, Wieczorek L, Sanders-Buell E, Rosa Borges A, Robb ML, Birx DL, Michael NL, McCutchan FE, Polonis VR.

Virology. 2008 Jun 5;375(2):529-38. doi: 10.1016/j.virol.2008.02.022. Epub 2008 Apr 22.

23.

Exposure to wild primates among HIV-infected persons.

LeBreton M, Yang O, Tamoufe U, Mpoudi-Ngole E, Torimiro JN, Djoko CF, Carr JK, Tassy Prosser A, Rimoin AW, Birx DL, Burke DS, Wolfe ND.

Emerg Infect Dis. 2007 Oct;13(10):1579-82. doi: 10.3201/eid1310.070338.

24.

Induction of HIV-specific functional immune responses by a multiclade HIV-1 DNA vaccine candidate in healthy Ugandans.

Eller MA, Eller LA, Opollo MS, Ouma BJ, Oballah PO, Galley L, Karnasuta C, Kim SR, Robb ML, Michael NL, Kibuuka H, Wabwire-Mangen F, Graham BS, Birx DL, de Souza MS, Cox JH.

Vaccine. 2007 Nov 7;25(45):7737-42. Epub 2007 Sep 17.

PMID:
17920731
25.

A phase 1/2 comparative vaccine trial of the safety and immunogenicity of a CRF01_AE (subtype E) candidate vaccine: ALVAC-HIV (vCP1521) prime with oligomeric gp160 (92TH023/LAI-DID) or bivalent gp120 (CM235/SF2) boost.

Thongcharoen P, Suriyanon V, Paris RM, Khamboonruang C, de Souza MS, Ratto-Kim S, Karnasuta C, Polonis VR, Baglyos L, Habib RE, Gurunathan S, Barnett S, Brown AE, Birx DL, McNeil JG, Kim JH; Thai AIDS Vaccine Evaluation Group.

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):48-55.

PMID:
17909315
26.

Identification of CRF34_01B, a second circulating recombinant form unrelated to and more complex than CRF15_01B, among injecting drug users in northern Thailand.

Tovanabutra S, Kijak GH, Beyrer C, Gammon-Richardson C, Sakkhachornphop S, Vongchak T, Jittiwutikarn J, Razak MH, Sanders-Buell E, Robb ML, Suriyanon V, Birx DL, Michael NL, Celentano DD, McCutchan FE.

AIDS Res Hum Retroviruses. 2007 Jun;23(6):829-33.

PMID:
17604547
27.

High prevalence of HIV infection among rural tea plantation residents in Kericho, Kenya.

Foglia G, Sateren WB, Renzullo PO, Bautista CT, Langat L, Wasunna MK, Singer DE, Scott PT, Robb ML, Birx DL.

Epidemiol Infect. 2008 May;136(5):694-702. Epub 2007 Jun 29.

28.

The protective effect of circumcision on HIV incidence in rural low-risk men circumcised predominantly by traditional circumcisers in Kenya: two-year follow-up of the Kericho HIV Cohort Study.

Shaffer DN, Bautista CT, Sateren WB, Sawe FK, Kiplangat SC, Miruka AO, Renzullo PO, Scott PT, Robb ML, Michael NL, Birx DL.

J Acquir Immune Defic Syndr. 2007 Aug 1;45(4):371-9.

PMID:
17558336
29.

Genetic characterization of HIV-1 strains circulating in Kazakhstan.

Eyzaguirre LM, Erasilova IB, Nadai Y, Saad MD, Kovtunenko NG, Gomatos PJ, Zeman VV, Botros BA, Sanchez JL, Birx DL, Earhart KC, Carr JK.

J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):19-23.

PMID:
17514018
30.

HIV-1 genetic diversity and compartmentalization in mother/infant pairs infected with CRF01_AE.

Tovanabutra S, de Souza M, Sittisombut N, Sriplienchan S, Ketsararat V, Birx DL, Khamboonrueng C, Nelson KE, McCutchan FE, Robb ML.

AIDS. 2007 May 11;21(8):1050-3.

PMID:
17457103
31.

HyperPack: a software package for the study of levels, contexts, and patterns of APOBEC-mediated hypermutation in HIV.

Kijak GH, Janini M, Tovanabutra S, Sanders-Buell EE, Birx DL, Robb ML, Michael NL, McCutchan FE.

AIDS Res Hum Retroviruses. 2007 Apr;23(4):554-7.

PMID:
17451344
32.

Frequency of CCR5 variants among rural populations with low HIV-1 prevalence in Cameroon.

Torimiro JN, Wolfe ND, Thomas A, Martin MP, Mpoudi-Ngole E, Tamoufe U, Birx DL, Carrington M, Burke DS, Carr JK.

AIDS. 2007 Feb 19;21(4):527-8.

PMID:
17301575
33.

Monoclonal antibodies to phosphatidylinositol phosphate neutralize human immunodeficiency virus type 1: role of phosphate-binding subsites.

Brown BK, Karasavvas N, Beck Z, Matyas GR, Birx DL, Polonis VR, Alving CR.

J Virol. 2007 Feb;81(4):2087-91. Epub 2006 Dec 6.

34.

Distinguishing molecular forms of HIV-1 in Asia with a high-throughput, fluorescent genotyping assay, MHAbce v.2.

Kijak GH, Tovanabutra S, Sanders-Buell E, Watanaveeradej V, de Souza MS, Nelson KE, Ketsararat V, Gulgolgarn V, Wera-arpachai M, Sriplienchan S, Khamboonrueng C, Birx DL, Robb ML, McCutchan FE.

Virology. 2007 Feb 5;358(1):178-91. Epub 2006 Sep 25.

35.

HIV incidence trends among white and african-american active duty United States Army personnel (1986-2003).

Bautista CT, Sateren WB, Sanchez JL, Rathore Z, Singer DE, Birx DL, Scott PT.

J Acquir Immune Defic Syndr. 2006 Nov 1;43(3):351-5.

PMID:
16980911
36.

Higher HIV-1 incidence and genetic complexity along main roads in Rakai District, Uganda.

Arroyo MA, Sateren WB, Serwadda D, Gray RH, Wawer MJ, Sewankambo NK, Kiwanuka N, Kigozi G, Wabwire-Mangen F, Eller M, Eller LA, Birx DL, Robb ML, McCutchan FE.

J Acquir Immune Defic Syndr. 2006 Dec 1;43(4):440-5.

PMID:
16980909
37.

Molecular epidemiology of HIV Type 1 in preparation for a Phase III prime-boost vaccine trial in Thailand and a new approach to HIV Type 1 genotyping.

Watanaveeradej V, Benenson MW, Souza MD, Sirisopana N, Nitayaphan S, Tontichaivanich C, Amphaipit R, Renzullo PO, Brown AE, McNeil JG, Robb ML, Birx DL, Tovanabutra S, Carr JK, McCutchan FE.

AIDS Res Hum Retroviruses. 2006 Aug;22(8):801-7.

PMID:
16910837
38.

Molecular epidemiology of HIV Type 1 in Ukraine: birthplace of an epidemic.

Saad MD, Shcherbinskaya AM, Nadai Y, Kruglov YV, Antonenko SV, Lyullchuk MG, Kravchenko ON, Earhart KC, Sanchez JL, Birx DL, Carr JK.

AIDS Res Hum Retroviruses. 2006 Aug;22(8):709-14.

PMID:
16910825
39.

Epidemiology of HIV-1 infection in agricultural plantation residents in Kericho, Kenya: preparation for vaccine feasibility studies.

Sateren WB, Foglia G, Renzullo PO, Elson L, Wasunna M, Bautista CT, Birx DL.

J Acquir Immune Defic Syndr. 2006 Sep;43(1):102-6.

PMID:
16885773
40.
41.

Circulating and unique recombinant forms of HIV type 1 containing subsubtype A2.

Visawapoka U, Tovanabutra S, Currier JR, Cox JH, Mason CJ, Wasunna M, Ponglikitmongkol M, Dowling WE, Robb ML, Birx DL, McCutchan FE.

AIDS Res Hum Retroviruses. 2006 Jul;22(7):695-702.

PMID:
16831094
42.

Frequency of HIV type 1 dual infection and HIV diversity: analysis of low- and high-risk populations in Mbeya Region, Tanzania.

Herbinger KH, Gerhardt M, Piyasirisilp S, Mloka D, Arroyo MA, Hoffmann O, Maboko L, Birx DL, Mmbando D, McCutchan FE, Hoelscher M.

AIDS Res Hum Retroviruses. 2006 Jul;22(7):599-606.

PMID:
16831083
43.

Trends in HIV prevalence among white and African-American civilian applicants for United States Military Service, 1985 to 2003.

Bautista CT, Sateren WB, Singer DE, Carr JK, Birx DL, Sanchez JL.

J Acquir Immune Defic Syndr. 2006 May;42(1):68-74.

PMID:
16763492
45.

HLA class I diversity among rural rainforest inhabitants in Cameroon: identification of A*2612-B*4407 haplotype.

Torimiro JN, Carr JK, Wolfe ND, Karacki P, Martin MP, Gao X, Tamoufe U, Thomas A, Ngole EM, Birx DL, McCutchan FE, Burke DS, Carrington M.

Tissue Antigens. 2006 Jan;67(1):30-7.

PMID:
16451198
46.

Use of stored serum from Uganda for development and evaluation of a human immunodeficiency virus type 1 testing algorithm involving multiple rapid immunoassays.

Singer DE, Kiwanuka N, Serwadda D, Nalugoda F, Hird L, Bulken-Hoover J, Kigozi G, Malia JA, Calero EK, Sateren W, Robb ML, Wabwire-Mangen F, Wawer M, Gray RH, Sewankambo N, Birx DL, Michael NL.

J Clin Microbiol. 2005 Oct;43(10):5312-5.

47.

In-depth analysis of a heterosexually acquired human immunodeficiency virus type 1 superinfection: evolution, temporal fluctuation, and intercompartment dynamics from the seronegative window period through 30 months postinfection.

McCutchan FE, Hoelscher M, Tovanabutra S, Piyasirisilp S, Sanders-Buell E, Ramos G, Jagodzinski L, Polonis V, Maboko L, Mmbando D, Hoffmann O, Riedner G, von Sonnenburg F, Robb M, Birx DL.

J Virol. 2005 Sep;79(18):11693-704.

48.

HIV-1 diversity and prevalence differ between urban and rural areas in the Mbeya region of Tanzania.

Arroyo MA, Hoelscher M, Sateren W, Samky E, Maboko L, Hoffmann O, Kijak G, Robb M, Birx DL, McCutchan FE.

AIDS. 2005 Sep 23;19(14):1517-24.

PMID:
16135906
49.

Prevalences, genotypes, and risk factors for HIV transmission in South America.

Montano SM, Sanchez JL, Laguna-Torres A, Cuchi P, Avila MM, Weissenbacher M, Serra M, Viñoles J, Russi JC, Aguayo N, Galeano AH, Gianella A, Andrade R, Arredondo A, Ramirez E, Acosta ME, Alava A, Montoya O, Guevara A, Manrique H, Sanchez JL, Lama JR, de la Hoz F, Sanchez GI, Ayala C, Pacheco ME, Carrion G, Chauca G, Perez JJ, Negrete M, Russell KL, Bautista CT, Olson JG, Watts DM, Birx DL, Carr JK; South American HIV Molecular Surveillance Working Group.

J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):57-64.

PMID:
16123683
50.

Outbreak of a West African recombinant of HIV-1 in Tashkent, Uzbekistan.

Carr JK, Nadai Y, Eyzaguirre L, Saad MD, Khakimov MM, Yakubov SK, Birx DL, Graham RR, Wolfe ND, Earhart KC, Sanchez JL.

J Acquir Immune Defic Syndr. 2005 Aug 15;39(5):570-5.

PMID:
16044009

Supplemental Content

Support Center